China - Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingHuman And Animal Blood Prices in China
China Human And Animal Blood Export Price in September 2022
In September 2022, the human and animal blood price stood at $188 per kg (FOB, China), reducing by -31.1% against the previous month. Overall, the export price recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in February 2022 an increase of 46% m-o-m. As a result, the export price attained the peak level of $294K per ton. From March 2022 to September 2022, the the average export prices remained at a somewhat lower figure.
As there is only one major export destination, the average price level is determined by prices for the United States.
From January 2022 to September 2022, the rate of growth in terms of prices for India amounted to +82.6% per month.
China Human And Animal Blood Exports
After three months of growth, overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by -47.1% to 3 tons in September 2022. Overall, exports continue to indicate a deep slump. The most prominent rate of growth was recorded in April 2022 when exports increased by 41% m-o-m. Over the period under review, the exports reached the peak figure at 14 tons in January 2022; afterwards, it flattened through to September 2022.
In value terms, human and animal blood exports shrank sharply to $555K (IndexBox estimates) in September 2022. Over the period under review, exports continue to indicate a abrupt descent. The most prominent rate of growth was recorded in August 2022 when exports increased by 66% month-to-month. The exports peaked at 2.8K tons in January 2022; however, from February 2022 to September 2022, the exports failed to regain momentum.
China Human And Animal Blood Exports by Country
the United States (2.9 tons) was the main destination for human and animal blood exports from China, with a approximately 99% share of total exports.
From January 2022 to September 2022, the average monthly rate of growth in terms of volume to the United States totaled -5.8%.
In value terms, the United States ($531K) also remains the key foreign market for human and animal blood exports from China.
From January 2022 to September 2022, the average monthly growth rate of value to the United States stood at -11.5%.
This report provides an in-depth analysis of the market for human and animal blood in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
313
This report provides an in-depth analysis of the market for human and animal blood in China.
504
This report provides an in-depth analysis of the antisera market in China.
338
This report provides an in-depth analysis of the biological product market in China.
435
This report provides an in-depth analysis of the vaccine market in China.
355
This report provides an in-depth analysis of the veterinary medicine vaccines market in China.
502
This report provides an in-depth analysis of the global market for human and animal blood.
1989
This report provides an in-depth analysis of the global antisera market.
430
This report provides an in-depth analysis of the global biological product market.
2601
This report provides an in-depth analysis of the global vaccine market.
649
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
52
Merck has temporarily halted Gardasil shipments to China due to reduced demand, impacting 2025 revenue forecasts, while Keytruda sales remain strong.
68
Merck's earnings aligned with Wall Street expectations, yet stocks fell due to a lackluster 2025 forecast. The company's reliance on products like Gardasil and Keytruda amid Chinese market challenges is under scrutiny.
913
Explore the top import markets for human and animal blood and their key statistics. Find out which countries are leading in the import of blood products.
88
Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
224
The article provides insights into the anticipated growth of the global market for antisera and other blood fractions over the next seven years, driven by increasing demand. Market performance is forecasted to expand with a CAGR of +1.7% in volume terms and +6.5% in value terms, reaching 707K tons and $580.4B respectively by the end of 2030.
667
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1717
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1310
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1531
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1601
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
